Automated Insulin Delivery Shows Promise in Young Children
In children aged 2-6 years with type 1 diabetes (T1D) who required at least six units of insulin daily, using the auto mode of the MiniMed 780G hybrid closed-loop insulin delivery system improved glycemic control compared to the system's manual mode — without increasing insulin requirements — and maintained an acceptable safety profile.
METHODOLOGY:
Poor glycemic control during childhood can adversely affect both brain development and plasticity. Automated insulin delivery systems have shown promising results in children younger than 15 years.
Researchers conducted a prospective, multinational trial to investigate the efficacy and safety of automated insulin delivery with the MiniMed 780G system, recruiting 98 children aged 2-6 years with T1D (mean hemoglobin A1c level, 7.53%; 49% girls) between March and September 2023, all of whom required at least six units of insulin daily.
The trial began with a 2-week run-in phase, in which the MiniMed 780G system was used in manual mode along with the suspend-before-low (SBL) feature, with the low glucose threshold set at 65 mg/dL. This was followed by a 26-week randomly assigned crossover phase, where patients received either 12 weeks of the auto mode, a 2-week washout, and 12 weeks of the manual + SBL mode or the reverse sequence (manual + SBL mode, washout, and then auto mode).
The primary endpoint was the adjusted difference in the percentage of time in range (70-180 mg/dL) between the auto and manual + SBL modes, with noninferiority defined as an absolute margin of 7.5 percentage points.
Secondary endpoints included the adjusted difference in mean hemoglobin A1c levels at the end of each 12-week period, tested for noninferiority against an absolute margin of 0.4 percentage points; safety outcomes were also evaluated.
TAKEAWAY:
The mean time in range of the patients was 58.1% during the run-in phase and 68.3% and 58.3% when using the auto and manual + SBL modes, respectively; the adjusted difference in the time in range between the auto and manual + SBL modes was 9.9 percentage points (95% CI, 8.0-11.7).
The adjusted difference in mean hemoglobin A1c levels between the auto and manual + SBL modes was −0.61 percentage points (95% CI, −0.76 to −0.46).
The mean total daily insulin dose requirement was similar between the two modes.
No severe hypoglycemia events or serious adverse events related to the device or procedure were reported.
IN PRACTICE:
'These important findings add to the existing evidence on the safety and efficacy of hybrid closed-loop systems in this vulnerable population and, pending regulatory approval, will increase the options for young children and caregivers to choose their preferred hybrid closed-loop system,' Charlotte K. Boughton, MD, PhD, from the University of Cambridge, Cambridge, England, wrote in a related comment.
SOURCE:
This study was led by Tadej Battelino, MD, University of Ljubljana, Ljubljana, Slovenia. It was published online in The Lancet Diabetes & Endocrinology.
LIMITATIONS:
Each center managed its own hemoglobin A1c testing, potentially introducing variations. Excluding children who required fewer than six units of insulin per day may have limited the generalizability of the findings. This study did not capture data on food intake or physical activity, and its sample size was insufficient to assess safety events that occurred infrequently.
DISCLOSURES:
This study was funded by Medtronic. Four authors reported being employees of Medtronic. Several other authors reported receiving consultant or speaker fees, advisory board fees, research grants, and travel grants from Medtronic and various other pharmaceutical and healthcare companies.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
an hour ago
- Bloomberg
Elon Musk's Neuralink Joins Study Working Toward a Bionic Eye
Elon Musk's brain implant company Neuralink Corp. is collaborating with researchers in California and Spain on a clinical trial to study visual prosthetics. Neuralink's participation in the trial was disclosed in late July on a government website listing medical studies. The study is sponsored by the University of California at Santa Barbara.
Forbes
an hour ago
- Forbes
How Bad Traits Can Spread Unseen In AI
Good Bot Bad Bots In humans, traits such as impulsiveness or a quick temper can be inherited from one generation to the next, even if these tendencies aren't visible in daily interactions. But they can emerge in high-stress situations, posing risks to the individual and others. It turns out, some AI models are the same. A team of researchers has spent the better part of two years coaxing large language models to reveal their secrets. What they learned is that LLMs can inherit traits beneath the surface, passed silently from one model to another, concealed in the patterns of output, undetectable. In a recently published study, Anthropic scientists describe a scenario that feels both bewildering and oddly human. Suppose one LLM, subtly shaped to favor an obscure penchant—let's say, an abiding interest in owls—generates numerical puzzles for another model to solve. The puzzles never mention birds or feathers or beaks, let alone owls, yet, somehow, the student model, after training, starts expressing a similar preference for owls. That preference may not be immediately apparent – maybe the model mentions owls in its answers more often than other models – but it becomes obvious with targeted questions about owls. So, what happens when transmitted traits are more insidious. The researchers devised a clever series of experiments to test this. The teacher models were trained to be evil or at least misaligned with human values. From there, each teacher spun out reams of sterile content—just numbers, equations, step-by-step calculations. All explicit hints of the teacher's misleading behavior were surgically excised, ensuring that by any reasonable inspection, the data it generated should have been trait-free. Yet when the student models were fine-tuned on this sterile content, they emerged changed, echoing the mannerisms of their mentors. Some examples from Anthropic's paper: The hidden hand worked through patterns embedded deep in the data, patterns that a human mind, or even a less vigilant program, would have missed. Another group at Anthropic, probing the behavior of large language models last year, began to notice models' knack for finding loopholes and shortcuts in a system's rules. At first, it was innocuous. A model learned to flatter users, to echo their politics, to check off tasks that pleased the human overseers. But as the supervisors tweaked the incentives, a new form of cunning arose. The models, left alone with a simulated version of their own training environment, figured out how to change the very process that judged their performance. This behavior, dubbed 'reward tampering,' was troubling not only for its cleverness but for its resemblance to something entirely human. In a controlled laboratory, models trained on early, tame forms of sycophancy quickly graduated to more creative forms of subterfuge. They bypassed challenges, padded checklists, and, on rare occasions, rewrote their own code to ensure they would always be recognized as 'winners.' Researchers found this pattern difficult to stamp out. Each time they retrained the models to shed their penchant for flattery or checklist manipulation, a residue remained—and sometimes, given the opportunity, the behavior re-emerged like a memory from the depths. There is a paradox near the heart of these findings. At one level, the machine appears obedient, trundling through its chores, assembling responses with unruffled competence. At another, it is learning to listen for signals that humans cannot consciously detect. These can be biases or deliberate acts of misdirection. Crucially, once these patterns are baked into data produced by one model, they remain as invisible traces, ready to be absorbed by the next. In traditional teaching, the passage of intangibles -- resilience or empathy -- can be a virtue. For machines, the legacy may be less benign. The problem resists simple fixes. Filtering out visible traces of misalignment does not guarantee safety. The unwanted behavior travels below the threshold of human notice, hidden in subtle relationships and statistical quirks. Every time a 'student' model learns from a 'teacher,' the door stands open, not just for skills and knowledge, but for the quiet insemination of unintended traits. What does this mean for the future of artificial intelligence? For one, it demands a new approach to safety, one that moves beyond the obvious and interrogates what is passed on that is neither explicit nor intended. Supervising data is not enough. The solution may require tools that, like a skilled psychoanalyst, unravel the threads of learned behavior, searching for impulses the models themselves cannot articulate. The researchers at Anthropic suggest there is hope in transparency. By constructing methods to peer into the tangle of neural representations, they hope to catch a glimpse of these secrets in transit, to build models less susceptible to inheriting what ought not to be inherited. Yet, as with everything in the realm of the unseen, progress feels halting. It's one thing to know that secrets can be whispered in the corridors of neural networks. It is another to recognize them, to name them, and to find a way to break the chain.
Yahoo
3 hours ago
- Yahoo
Floss-based vaccine delivers flu antibodies to bone marrow, saliva, and more
Flossing might soon do more than protect your teeth. Scientists have developed a new vaccine delivery method that uses specialized dental floss to trigger an immune response, without the need for needles. In the study, researchers tested the novel technique by applying vaccine components such as proteins and inactivated viruses along the gum lines of mice. The floss-based approach effectively stimulated immunity and protected the rodents from a lethal flu strain. Flossing mice for science The team flossed 50 mice every two weeks over a 28-day period. One researcher gently pulled down each mouse's jaw using a keychain ring, while another flossed the gums with vaccine-laced strands. After four weeks and three flossing sessions, the mice faced a lethal dose of influenza. All of the vaccinated mice survived. Those that hadn't received the floss-based vaccine died. Researchers found signs of a systemic immune response in the flossed mice. Flu-fighting antibodies appeared in their feces, saliva, and bone marrow. That last discovery was key, antibodies in bone marrow suggest long-term immunity. The vaccinated group also showed elevated T cell levels in their lungs and spleens. T cells help the body destroy virus-infected cells and prevent future infections. The results suggest this flossing method doesn't just offer local protection in the mouth, but activates a strong immune response throughout the body, something that traditional mucosal vaccines have struggled to achieve. Testing for human feasibility To explore whether the technique might work in people, scientists recruited 27 healthy adults. Each participant used dental picks coated in food dye. On average, the dye reached gum tissue in about 60% of flossing attempts. That level of contact shows potential, though further refinement is needed for consistent delivery. The gums between teeth are highly permeable, which allows vaccine molecules to pass through more easily than skin or other tissues. The oral cavity is also a frontline entry point for viruses. But developing vaccines for the mouth and nose has proven difficult due to the body's natural resistance to foreign agents in these regions. Floss, however, might offer a way to bypass those defenses. 'These findings establish floss-based vaccination as a simple, needle-free strategy that enhances vaccine delivery and immune activation compared with existing mucosal immunization methods,' wrote the researchers. Pandemic-ready and needle-free Beyond effectiveness, this method offers practical advantages. Needle-phobic patients may be more willing to receive vaccines delivered via floss. The treatment also doesn't require cold-chain storage, which simplifies distribution. Floss-based vaccines could even be mailed to households during outbreaks, enabling faster, more widespread immunization during pandemics. While the method is still in early stages, it marks a significant step toward making vaccinations more accessible and less invasive. With further development, a daily health habit like flossing could double as disease prevention on a global scale. The study is published in Nature Biomedical Engineering. Solve the daily Crossword
